New GLP-1 RA ‘better than semaglutide’ for weight loss in Lancet study
A high dose of a new once-weekly injected GLP-1 receptor agonist has outdone semaglutide for weight loss in a phase III trial. Ecnoglutide, developed in…
A high dose of a new once-weekly injected GLP-1 receptor agonist has outdone semaglutide for weight loss in a phase III trial. Ecnoglutide, developed in…
AI search engine OpenEvidence has struck deals with JAMA and The New England Journal of Medicine to try to give fully cited answers to medical…
Find bad medical evidence before it kills people. That is the motto of the newly launched Medical Evidence Project. It was set up by the…
CRISPR technology has shown strong results treating a baby with a life-threatening liver cell mutation, with scientists saying it is the first documented use of…
Every retracted study may influence the results of three systematic reviews, each of which subsequently infects three clinical practice guidelines, researchers warn. Writing in The…
More than 30 pain medicine societies are calling on The BMJ to retract a clinical practice guideline that advises against interventional procedures for chronic spine…
This article has been corrected (see footnote). Mandatory research projects in specialist training programs may waste registrars’ time and add to the global pit of…
What are the big unknowns in general practice? No, not the reasons for the existence of the authority script line or whether obesity is a…
Researchers are fighting the centuries-old tradition of unpaid peer review, claiming that publishers are banking huge profits off the back of their free labour. Four…
Pressure to publish new findings is a key reason reproducibility studies are being pushed to the wayside, researchers say. Despite being a crucial test of…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.